Buprenorphine/naloxone
NIDA-CTN-0027
Approved small_molecule completed
Quick answer
Buprenorphine/naloxone for Opiate-related Disorders is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Opiate-related Disorders
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed